Latest Breaking News On - Beyond batten disease foundation - Page 6 : comparemela.com

New Advance to the Theranexus and BBDF Batten-1 Program for Juvenile Batten Disease (CLN3)

New Advance to the Theranexus and BBDF Batten-1 Program for Juvenile Batten Disease (CLN3)
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalSan franciscoCraig bensonMarie sebilleNational organization for rare disordersNeuroscience innovation forumAtomic energy commissionBatten disease foundationSachs associatesBeyond batten disease foundationTheranexu chief medical officer marie sebilleAnnual neuroscience innovation forumBiotech showcaseHealthcare conferenceUnified batten disease rating scale

New Advance to the Theranexus and BBDF Batten-1 Program for Juvenile Batten Disease (CLN3)

New Advance to the Theranexus and BBDF Batten-1 Program for Juvenile Batten Disease (CLN3)
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

THERANEXUS AND BBDF PRESENT PROGRESS ON THE BATTEN-1 PROGRAM AT THE TRANSLATIONAL RESEARCH CONFERENCE FOR THE MANAGEMENT OF NCLS ON 3 AND 4 NOVEMBER, 2022 IN CHICAGO

Lyon, France - Austin, Texas, United States - 2 November 2022 - 6pm CET - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development

United statesFrance generalThierry lambertMathieu charvFlorence portejoieMartin pierre laurentEmyr lloyd evansCardiff university school of biosciencesNational organization for rare disordersTranslational research conference for the managementAtomic energy commissionBatten disease foundationBeyond batten disease foundationCardiff universityTranslational research conferenceCardiff university school

THERANEXUS: Theranexus and BBDF finalize recruitment for phase I/II trial to evaluate Batten-1 in Batten disease

Lyon, France - Austin, Texas, United States - 8 September 2022 - 6 pm CEST - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development

United statesFrance generalGary clarkCraig bensonThierry lambertFlorence portejoieMartin pierre laurentFranck mouthonNational organization for rare disordersAtomic energy commissionBatten disease foundationBeyond batten disease foundationChild neurologyTexas childrenFrench alternative energiesEuronext growth

Parents Become Drug Developers to Save Their Children s Lives

Parents Become Drug Developers to Save Their Children s Lives
physiciansweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from physiciansweekly.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoEl pasoUniversity of texas southwestern medical centerJames geraghtyCraig bensonMark cubanMaggie pearlEthan perlsteinJoe panettaMartin shkreliAlok tayiHolly carmichaelCourtney boggsMaggie carmichaelSteven gray